Cardiovascular Morbidity and Mortality in Fabry Disease
Circulation: Genomic and Precision Medicine · 2026
DOI: 10.1161/circgen.125.005361 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Genomic and Precision Medicine, 2026. Verfasst von Emanuele Monda und 20 weiteren Autor:innen. Beteiligte Einrichtung: Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Monaldi Hospital, …. Hauptthemen laut MEDLINE: Fabry Disease, Cardiovascular Diseases. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Cardiac involvement is the main determinant of adverse outcomes in Fabry disease. The study aimed to investigate cardiovascular outcomes in patients with Fabry disease. METHODS: This was a multicenter, retrospective, longitudinal study of consecutively referred adult patients with Fabry disease. The primary end point was the occurrence of major adverse cardiovascular events defined as a composite of cardiovascular death, major arrhythmic events, bradyarrhythmias requiring pacemaker implantation, and stroke. RESULTS: A total of 680 patients (age, 42.3±15.9 years; 41.0% male; 68.7% on disease-specific therapy) were included. During a median follow-up of 7.1 (interquartile range, 3.9–11.6) years, 92 patients (13.5%) experienced a major adverse cardiovascular event. At 10 years, freedom from major adverse cardiovascular event was 85.1% (95% CI, 81.3–88.2) and was lower in males compared with females (76.1% [95% CI, 68.9–81.9] versus 91.3% [95% CI, 87.0–94.2]; log-rank χ 2 =26.9; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Monaldi Hospital, Naples, Italy (E. Monda, M.R., G.L.).
- Institute of Cardiovascular Science (E. Monda, A.B., G.L., P.M.E.), University College London, United Kingdom.
- European Reference Network for Rare, Low Prevalence & Complex Diseases of the Heart-ERN GUARD-Heart, Florence, Italy (E. Monda, V.P., M.A.S., M.R., E.B., G.L.).
- Cardiomyopathy Unit, Department of Experimental and Clinical Medicine, University of Florence, Italy (A.D.F., F.C., M.P.).
- Department of Cardiovascular Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy (R. Lillo, M.C.M., F.G.).
- Department of Clinical Medicine and Surgery (L.S., G.I.), Federico II University, Naples, Italy.
ORCID-Profile: Emanuele Monda, Athanasios Bakalakos, Annamaria Del Franco, Rosa Lillo, Maria Chiara Meucci, Letizia Spinelli, Maria Alessandra Schiavo, Francesca Graziani, Francesco Cappelli, Maurizio Pieroni, Antonio Pisani, Guido Iaccarino, Robin Lachmann, Elaine Murphy, Uma Ramaswami, Derralynn Hughes, Elena Biagini, Giuseppe Limongelli, Perry Mark Elliott
Zitieren
APA
Monda, E., Bakalakos, A., Del Franco, A., Lillo, R., Meucci, M. C., Spinelli, L., Parisi, V., Schiavo, M. A., Rubino, M., Graziani, F., Cappelli, F., Pieroni, M., Pisani, A., Iaccarino, G., Lachmann, R., Murphy, E., Ramaswami, U., Hughes, D., Biagini, E., …, & Elliott, P. M. (2026). Cardiovascular Morbidity and Mortality in Fabry Disease. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.125.005361
Vancouver
Monda E, Bakalakos A, Del Franco A, Lillo R, Meucci MC, Spinelli L, et al. Cardiovascular Morbidity and Mortality in Fabry Disease. Circulation: Genomic and Precision Medicine. 2026. doi:10.1161/circgen.125.005361
BibTeX
@article{Monda2026,
author = {Monda, Emanuele and Bakalakos, Athanasios and Del Franco, Annamaria and Lillo, Rosa and Meucci, Maria Chiara and Spinelli, Letizia and Parisi, Vanda and Schiavo, Maria Alessandra and Rubino, Marta and Graziani, Francesca and Cappelli, Francesco and Pieroni, Maurizio and Pisani, Antonio and Iaccarino, Guido and Lachmann, Robin and Murphy, Elaine and Ramaswami, Uma and Hughes, Derralynn and Biagini, Elena and Limongelli, Giuseppe and Elliott, Perry Mark},
title = {Cardiovascular Morbidity and Mortality in Fabry Disease},
journal = {Circulation: Genomic and Precision Medicine},
year = {2026},
doi = {10.1161/circgen.125.005361}
}
EUVIMED